Product NDC: | 66521-200 |
Proprietary Name: | Influenza A (H1N1) 2009 Monovalent Vaccine |
Non Proprietary Name: | Influenza A (H1N1) 2009 Monovalent Vaccine |
Active Ingredient(s): | 15 ug/.5mL & nbsp; Influenza A (H1N1) 2009 Monovalent Vaccine |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION, SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66521-200 |
Labeler Name: | Novartis Vaccines and Diagnostics Ltd |
Product Type: | VACCINE |
FDA Application Number: | BLA103837 |
Marketing Category: | BLA |
Start Marketing Date: | 20090915 |
Package NDC: | 66521-200-10 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (66521-200-10) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 66521-200-10 |
Proprietary Name | Influenza A (H1N1) 2009 Monovalent Vaccine |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (66521-200-10) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 66521-200 |
Product Type Name | VACCINE |
Non Proprietary Name | Influenza A (H1N1) 2009 Monovalent Vaccine |
Dosage Form Name | INJECTION, SUSPENSION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20090915 |
Marketing Category Name | BLA |
Labeler Name | Novartis Vaccines and Diagnostics Ltd |
Substance Name | INFLUENZA A VIRUS A/CALIFORNIA/7/2009(H1N1)-LIKE HEMAGGLUTININ ANTIGEN (PROPIOLACTONE INACTIVATED) |
Strength Number | 15 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes |